107 related articles for article (PubMed ID: 9443608)
1. In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpene.
Egorin MJ; Rosen DM; Benjamin SE; Callery PS; Sentz DL; Eiseman JL
Cancer Chemother Pharmacol; 1997; 41(1):9-14. PubMed ID: 9443608
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
[TBL] [Abstract][Full Text] [Related]
3. Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemannii.
Egorin MJ; Sentz DL; Rosen DM; Ballesteros MF; Kearns CM; Callery PS; Eiseman JL
Cancer Chemother Pharmacol; 1996; 39(1-2):51-60. PubMed ID: 8995499
[TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies.
Kubic VL; Anders MW
Drug Metab Dispos; 1975; 3(2):104-12. PubMed ID: 236156
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of the styrene metabolite 4-vinylphenol by rat and mouse liver and lung.
Carlson GP; Perez Rivera AA; Mantick NA
J Toxicol Environ Health A; 2001 Aug; 63(7):541-51. PubMed ID: 11497334
[TBL] [Abstract][Full Text] [Related]
7. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.
Subrahmanyam V; Renwick AB; Walters DG; Young PJ; Price RJ; Tonelli AP; Lake BG
Drug Metab Dispos; 2001 Aug; 29(8):1146-55. PubMed ID: 11454734
[TBL] [Abstract][Full Text] [Related]
9. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450.
Miller KK; Cai J; Ripp SL; Pierce WM; Rushmore TH; Prough RA
Drug Metab Dispos; 2004 Mar; 32(3):305-13. PubMed ID: 14977864
[TBL] [Abstract][Full Text] [Related]
10. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450.
Karashima D; Hirokata Y; Shigematsu A; Furukawa T
J Pharmacol Exp Ther; 1977 Nov; 203(2):409-16. PubMed ID: 909072
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.
Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP
Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of haloforms to carbon monoxide. I. In vitro studies.
Ahmed AE; Kubic VL; Anders MW
Drug Metab Dispos; 1977; 5(2):198-204. PubMed ID: 15814
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis.
Saghir SA; Zhang F; Rick DL; Kan L; Bus JS; Bartels MJ
Regul Toxicol Pharmacol; 2010; 57(2-3):129-35. PubMed ID: 20096743
[TBL] [Abstract][Full Text] [Related]
14. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes.
Iwatsubo T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Yokoi T; Kamataki T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Aug; 282(2):909-19. PubMed ID: 9262358
[TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
16. Androgen-dependent renal microsomal cytochrome P-450 responsible for N-hydroxylation and mutagenic activation of 3-methoxy-4-aminoazobenzene in the BALB/c mouse.
Degawa M; Miura S; Hashimoto Y
Cancer Res; 1990 May; 50(9):2729-33. PubMed ID: 2328499
[TBL] [Abstract][Full Text] [Related]
17. Benzanthrone: a new substrate for hepatic microsomal cytochrome P-450.
Das M; Garg K; Singh GB; Khanna SK
Biochem Int; 1989 Jun; 18(6):1237-44. PubMed ID: 2751686
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
19. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
[TBL] [Abstract][Full Text] [Related]
20. Lack of mechanism-based inactivation of rat hepatic microsomal cytochromes P450 by doxorubicin.
Di Re J; Lee C; Riddick DS
Can J Physiol Pharmacol; 1999 Aug; 77(8):589-97. PubMed ID: 10543722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
